medigraphic.com
ISSN 1025-0255 (Electronic)

2012, Number 4

<< Back

AMC 2012; 16 (4)

Decision trees for the diagnosis and treatment of patients with neovascular glaucoma

Landín SM, Romero SRE

Language: Spanish
References: 30
Page: 514-527
PDF size: 405.84 Kb.


ABSTRACT

Introduction: epidemiological studies related to secondary glaucoma all over the world, as it is the case of neovascular one, they are rare when compared with simple chronic glaucoma.
Development: a literature review on diagnosis and treatment of neovascular glaucoma was carried out. Decision trees technique, based on medical histories of patients as well as the results of the multivariate statistical analysis of the study was used. The results of the statistical and theoretical analysis were presented which facilitated the achievement of decision trees as an expression of diagnosis and treatment uniformity.


REFERENCES

  1. Quigley HA. Estudio de Harold. Br J Ophthalmol. 1996; 80:389-93.

  2. Quigley HA, West SK. The prevalence of glaucoma in a population based study of hispanic subjects. Arch Ophthalmol. 2001; 119:1819.

  3. Gadia R. Current profile of secondary Glaucomas. Indian J Ophthalmol. 2008 Jul-Aug; 56(4):285-9.

  4. Krishnadas R, Ramakrishnan R. Secondary Glaucomas: The Tasks Ahead. Community Eye Health. 2001; 14(39):40-2.

  5. Khan Y. Neovascular Glaucoma. eMedicine [Internet]. 2006 Jun [citado 11 Dic 2008]; 135:[aprox. 9 p.]. Disponible en: http://www.emedicine.com/OPH/topic135.htm

  6. Shazly TA, Latina MA. Neovascular Glaucoma: Etiology, Diagnosis and Prognosis. Inf health care [Internet]. 2009 [citado 11 Dic 2008]; 24(2): [aprox. 8 p.]. Disponible en: http://informahealthcare.com/doi/abs/10.1080/08820530902800801

  7. González de Dios J. De la medicina basada en la evidencia a la evidencia basada en la medicina. Anal Esp Pediat. 2001; 55(5):429-39.

  8. Sánchez-Pedraza R, Gamboa O. Modelos empleados para la Toma de Decisiones en el Cuidado de la Salud. Rev Salud Pública [Internet]. 2008 [citado 11 Dic 2008]; 10(1): [aprox. 10 p.]. Disponible en: http://www.scielosp.org/pdf/rsap/v10n1/v10n1a17.pdf

  9. Sánchez de Gomez C. Árboles de Decisión [Internet]. Argentina: Zunal; 2008 [citado 11 Dic 2010]. Disponible en: http://zunal.com/introduction.php?user=29886

  10. Johnson CA. The Decision Tree in Glaucoma Diagnosis. Rev Optometry. 2009; 1-2(146):100-7.

  11. Engelbert M, Aswad Lama AL. Neovascular Glaucoma. Cont Ophthalmol. 2008; 7(5):1-6.

  12. Revoptom O. Handbook of Ocular Diseases Management. Neovascular Glaucoma [Internet]. New York: Mosby; 2006. Available from: http://www.revoptom.com/handbook/SECT35a.HTM

  13. Al-Aswad L. Treating Neovascular Glaucoma: A surgeon summarizes the signs, symptoms and appropriate treatment for this problematic disease. Review of ophthalmol [Internet]. 2005 Ene; 12(08): [about 12 p.]. Disponible en:http://www.revophth.com/index.asp?page=1_776.htm

  14. Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007 Sep; 26(5):470-85.

  15. Oya Y, Sugiyama W, Ando N. Anterior segment fluorescein angiography for evaluating the effect of vitrectomy for neovascular glaucoma. Nippon Ganka Gakkai Zasshi. 2005 Nov; 109(11):741-7.

  16. Harasymowycz PJ, Katz LJ. Ultrasound biomicroscopy and management of late posterior migration of a ripcord suture after glaucoma drainage implant surgery. Ophthalmic Surg Lasers Imaging. 2004 Mar-Apr; 35(2):149-51.

  17. Loffler KU. Neovascular glaucoma: aetiology, pathogenesis and treatment. Ophthalmologe. 2006 Dec; 103(12):1057-64.

  18. Sisto D, Vetrugno M. The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up. Acta [Internet]. 2007; 4(8):[about 9 p.]. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0420.2006.00810.x/full

  19. Delaney WV. Evidence-based recommendations for neovascular Glaucoma. Ophthalmology. 2003 Jan; 110(1):2-3.

  20. Palko Z. Therapeutic difficulties in neovascular glaucoma. Romanian Oftalmol. 2006; 50(2):73-6.

  21. Preda M, Davidescu L. Neovascular glaucoma prevention. Romanian Oftalmol. 2006; 50(2):108-14.

  22. Alekseev VN, Levko MA. Long-term results of secondary glaucoma surgical treatment. Vestn Oftalmol. 2011 Jan-Feb; 127(1):45-8.

  23. Rojas Rondó I, Rivas Canino MC. Uso de la triamcinolona subtenoniana en pacientes con rubeosis del iris. Rev Cubana Oftalmol [Internet]. 2008 [citado 12 Feb 2009]; 21(2):[aprox. 15 p.]. Disponible en: http://bvs.sld.cu/revistas/oft/vol21_2_08

  24. Faghihi H, Hajizadeh F. Pars plana Ahmed valve implant and vitrectomy in the Management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2007 Jul-Aug; 38(4):292-300.

  25. Miki A, Oshima Y. Efficacy of intravitreal Bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma. Br J Ophthalmol. 2008 Oct; 92(10):1431-3.

  26. Grover S, Gupta S. Intracameral Bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma. Br J Ophthalmol. 2009 Feb; 93(2):273-4.

  27. Holló G. Diabetic neovascularisation and secondary glaucoma. Orv Hetil. 2011 Jul 17; 152(29):1167-70.

  28. Castillo Nájera F, Pereda Girón M. Ojo ciego y doloroso. El dolor ocular crónico. Revista Dolor, Clínica y Terapia [Internet]. 2008 Ene-Feb [citado 22 Jul 2009]; (6):[aprox. 9 p.]. Disponible en: http://www.intramed.net/contenidover.asp?contenidoID=51334

  29. Pokroy R, Greenwald Y. Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2008 Jan-Feb; 39(1):22-9.

  30. Martínez Urbay JG, Depestre Pérez BG. Tratamiento del glaucoma absoluto doloroso mediante inyección retrobulbar de Clorpromazina. Rev Mis Milagro [Internet]. 2009 Abr-Jun [citado 19 Jun 2010]; 3(2):[aprox. 7 p.]. Disponible en: http://www.misionmilagro.sld.cu/vol3no2/inv3205.php




2020     |     www.medigraphic.com